The Science 37 Direct-to-Patient Site in Action: How Science 37 Accelerated Enrollment for a Dermatology Trial

A biopharma company was conducting a Phase II randomized controlled clinical trial in the United States for a dermatological condition. The trial protocol required participation by patients aged 18 or older with mild-to-moderate acne. The sponsor faced challenges with recruiting a diverse and representative patient population as well as study start-up time. Download this case study, and discover how the Science 37 Direct-to-Patient Site:

• Accelerated recruitment and enrollment
• Delivered 82% patient retention
• And enabled diversity to meet protocol skin tone requirements

Discover how a virtual site reduced patient burden with remote clinical trial conduct and delivered high-quality, compliant data to support the sponsor’s regulatory submission.